KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Short term Debt (2020 - 2025)

Organon has reported Short term Debt over the past 6 years, most recently at $16.0 million for Q4 2025.

  • Quarterly results put Short term Debt at $16.0 million for Q4 2025, down 20.0% from a year ago — trailing twelve months through Dec 2025 was $16.0 million (down 20.0% YoY), and the annual figure for FY2025 was $16.0 million, down 20.0%.
  • Short term Debt for Q4 2025 was $16.0 million at Organon, down from $45.0 million in the prior quarter.
  • Over the last five years, Short term Debt for OGN hit a ceiling of $1.5 billion in Q1 2021 and a floor of $8.0 million in Q3 2022.
  • Median Short term Debt over the past 5 years was $9.0 million (2021), compared with a mean of $98.9 million.
  • Biggest five-year swings in Short term Debt: tumbled 99.41% in 2022 and later soared 1177.78% in 2025.
  • Organon's Short term Debt stood at $9.0 million in 2021, then fell by 11.11% to $8.0 million in 2022, then grew by 12.5% to $9.0 million in 2023, then surged by 122.22% to $20.0 million in 2024, then decreased by 20.0% to $16.0 million in 2025.
  • The last three reported values for Short term Debt were $16.0 million (Q4 2025), $45.0 million (Q3 2025), and $115.0 million (Q2 2025) per Business Quant data.